Jonathan McNeill

Jonathan McNeill

Plus aucun poste en cours

Fortune : 3 M $ au 30/06/2026

41 ans
Consumer Services
Health Technology

Profil

Jonathan McNeill is President & Chief Operating Officer at Crescent Biopharma, Inc. since 2025.
Dr. McNeill is Partner at Forbion Capital Partners Management Holding since 2025.
Formerly, Dr. McNeill was Associate Director-Business Development at Editas Medicine, Inc. from 2015 to 2019.
Dr. McNeill was Vice President-Business Development at Dyne Therapeutics, Inc. from 2019 to 2021.
Dr. McNeill was President & Chief Operating Officer at Crescent Biopharma, Inc. (Old).
Education includes a doctorate and graduate degrees from the University of Pennsylvania Medical Center and the University of Pennsylvania in 2014, and an undergraduate degree from The University of North Carolina at Chapel Hill in 2007.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
0,5 %
22/06/2026 139 158 ( 0,5 % ) 3 M $ 30/06/2026

Postes actifs de Jonathan McNeill

SociétésPosteDébut

Anciens postes connus de Jonathan McNeill

SociétésPosteFin
DYNE THERAPEUTICS, INC. Corporate Officer/Principal 03/09/2024
EDITAS MEDICINE, INC. Corporate Officer/Principal 01/01/2019
Voir l'expérience en détail de Jonathan McNeill

Formation de Jonathan McNeill

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

88

Relations au 1er degré

5

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées5

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Jonathan McNeill
🔇